Sort
21,281 grants matching “influenza”
Development of a Universal Influenza Vaccine Produced by Cell-Free Protein Synthesis
$196,063Jeff C Fairman · Vaxcyte, Inc. · R43 · FY2016 · AI
Intracellular functions and mechanisms of alphavirus ion channel 6K
$196,044Joyce Jose · Pennsylvania State University, The · R21 · FY2024 · AI
Mechanism of Azithromycin Activity in Pseudomonas Infections
$196,032Alan R Hauser · Northwestern University At Chicago · R21 · FY2011 · AI
SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA BY NATIONAL
$196,031Aishath Abdulla · Health Protection Agency · U51 · FY2015 · IP
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
$196,012Jun Wang · State University New York Stony Brook · R21 · FY2021 · AI
A Genetic Locus that Regulates Susceptibility to Highly Pathogenic H5N1 Influenza Virus
$195,937Adrianus Cm Boon · Washington University · R21 · FY2019 · AI
CORE--NMR
$195,927University Of Alabama At Birmingham · P30 · FY2002 · CA
Modulation of immune senescence by androgen treatment in aged male macaques
$195,926Ilhem Messaoudi · University Of California Riverside · R21 · FY2014 · AG
Comparative Genomics
$195,870David J. Lipman · National Library Of Medicine · ZIA · FY2010 · LM
Vaccine-induced SARS-CoV-2-specific T cell responses in patients with X-linked Agammaglobulinemia
$195,770Kristina Abel · Univ Of North Carolina Chapel Hill · R21 · FY2024 · AI
Digital Nanobubble Biosensor for Respiratory Syncytial Virus Detection
$195,750Zhenpeng Qin · University Of Texas Dallas · R21 · FY2019 · AI
Epigenetic mediated long-term aberrations in myeloid cells after critical illness
$195,696Krzysztof Laudanski · University Of Pennsylvania · K23 · FY2020 · GM
Epigenetic mediated long-term aberrations in myeloid cells after critical illness
$195,696Krzysztof Laudanski · University Of Pennsylvania · K23 · FY2017 · GM
Epigenetic mediated long-term aberrations in myeloid cells after critical illness
$195,696Krzysztof Laudanski · University Of Pennsylvania · K23 · FY2019 · GM
Core C: Humoral and Serological Core
$195,681Scott Eric Hensley · Massachusetts General Hospital · U19 · FY2022 · AI
Strategy for global, unbiased mining and discovery of human monoclonal antibodies
$195,630Moonsoo M. Jin · Weill Medical Coll Of Cornell Univ · R21 · FY2013 · AI
Examining the Dynamic Architecture of the Influenza Virus Genome
$195,625Nara Lee · University Of Pittsburgh At Pittsburgh · R21 · FY2021 · AI
Role of antigen valency and pattern recognition receptor ligands in HPV vaccine-induced durable B cell memory
$195,625Erin M Scherer · Emory University · R21 · FY2023 · AI
Adjuvant combination for SARS-CoV-2 vaccine for the elderly
$195,625Elena Vassilieva · Emory University · R21 · FY2023 · AI
Assessing the impact of COVID-19 interventions on human mobility and SARS-CoV-2 transmission dynamics in the United States
$195,625Sean Michael Moore · University Of Notre Dame · R21 · FY2022 · AI
Midcareer Investigator Award in Patient-Oriented Research (K24)
$195,598Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2013 · AT
The effects of cells that survive direct influenza A virus infection on lung repair
$195,583Nicholas S Heaton · Duke University · R21 · FY2017 · AI
Comparative Effectiveness and Safety of Influenza Immunization Strategies in the Dialysis Population
$195,557Anne Mobley Butler · Washington University · R21 · FY2019 · AI
Mechanism of membrane inactivation method to prepare enveloped virus vaccines
$195,501Hector Aguilar-Carreno · Cornell University · R21 · FY2022 · AI
TRANSGENIC ANIMAL MODEL DEVELOPMENT--PKR PROTEIN KINASE
$195,486University Of Washington · R24 · FY2000 · RR